
A team of scientists from La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases
The scientific discovery, published in the prestigious journal Nature Communications could lead to the development of a new class of antibiotics and meet the challenge of rising antibiotic resistance.
Dr Mark Hulett and Dr Marc Kvansakul from the La Trobe Institute for Molecular Science said their team had demonstrated the peptide NaD1 found in the flowers of the ornamental tobacco plant Nicotiana alata has infection-busting qualities.
“Infectious diseases are a major global health problem, accounting for more than one in eight deaths and mortality rates are predicted to skyrocket over the next 30 years,” Dr Hulett said.
“Antibiotic resistance at the current rate will eventually lead to the exhaustion of effective long-term drug options. It’s imperative we develop new antibiotic treatments.”
Using the power of the Australian Synchrotron, the team led by Dr Hulett and Dr Kvansakul have shown in atomic detail how the tobacco plant peptide can target and destroy the micro-organism responsible for a dangerous fungal infection.
The peptide perforates the parachute-like outer layer of Candida albicans cells, ripping them apart and causing them to explode and die.
“They act in a different way to existing antibiotics and allow us to explore new ways of fighting infections.
“It’s an exciting discovery that could be harnessed to develop a new class of life-saving antimicrobial therapy to treat a range of infectious diseases, including multi-drug-resistant golden staph, and viral infections such as HIV, Zika virus, Dengue and Murray River Encephalitis.”
In 2014, Dr Hulett and Dr Kvansakul found NaD1 could also be effective in killing cancer cells.
Background
Candida albicans is responsible for life-threatening infections in immune-compromised patients, including those diagnosed with cancer and transplant recipients. There are limited effective antibiotics available to treat the infection.
Nicotiana alata flowers naturally produce potent anti-fungal molecules for protection against disease. The plant is related, but different, to tobacco plants grown for commercial use.
Learn more: La Trobe’s infection-busting discovery
The Latest on: Antimicrobial therapy
[google_news title=”” keyword=”antimicrobial therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antimicrobial therapy
- Ultrafast sepsis test pinpoints treatment in just 13 hourson July 23, 2024 at 5:00 pm
When they retrospectively obtained bacterial strains from six patients with confirmed sepsis, their platform shaved about 48 h off the process of identifying the right antimicrobial therapy. “The ...
- If Your Cold Lingers, Here Are 13 Things It Could Meanon July 23, 2024 at 7:52 am
If your cold symptoms won't quit, you may have something else. Doctors explain what it could mean if you've got a lingering "cold." The post If Your Cold Lingers, Here Are 13 Things It Could Mean ...
- The Promise of Bacteriophage Therapy to Fight Drug-Resistant Superbugson June 26, 2024 at 5:01 pm
Today, we're going to continue talking about AMR (antimicrobial resistance), cystic ... to meet with a doctor who specializes in phage therapy treatment -- through Diane, [who] had talked to ...
- The FDA needs to embrace phage therapy to help fight antimicrobial resistanceon June 22, 2024 at 5:00 pm
My daughter, Mallory, died in 2017 at the age of 25 from a multiply resistant bacterial lung infection that followed a double-lung transplant necessitated by cystic fibrosis. In the weeks before ...
- Travelers' Diarrhea: Antimicrobial Therapy and Chemopreventionon June 19, 2024 at 5:00 pm
The advice given is to allow the traveler to determine when to initiate therapy based on how they feel. Many debilitating enteric illnesses are associated with excessive abdominal complaints ...
- Challenges to Tackling Antimicrobial Resistanceon April 23, 2024 at 7:53 am
Patients infected with a resistant microorganism are less likely to recover with the first antimicrobial therapy and are likely to require extra investigation and treatment – and a number of ...
- Antimicrobial Stewardship & Healthcare Epidemiologyon May 6, 2023 at 11:50 am
This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site https://www.editorialmanager ...
- Catherine Liu, MDon December 15, 2018 at 12:40 am
She also directs the outpatient parenteral antimicrobial therapy program at Fred Hutch, which manages patients transitioning from hospitalization to an outpatient setting who require intravenous ...
- Antimicrobial Stewardship Programson January 30, 2012 at 3:12 am
route of administration and duration of antimicrobial therapy. Core members of the team should include a physician and a clinical pharmacist, both with training in infectious diseases with an ...
via Bing News